Enable JavaScript to visit this website.

What is XELJANZ?

XELJANZ (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with moderately to severely active ulcerative colitis

It is not known if XELJANZ is safe and effective in children or in people with Hepatitis B or C.

XELJANZ is not recommended for people with severe liver problems.

If I have been prescribed XELJANZ, am I eligible to receive a free trial offer?

If you are new to XELJANZ, your healthcare provider can request, or provide to you during your appointment, a 30-day trial prescription. Terms and conditions/eligibility requirements apply.